FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3191008658> ?p ?o ?g. }

• W3191008658 endingPage "2123" @default.
• W3191008658 startingPage "2112" @default.
• W3191008658 abstract "Abstract Aims Atrial fibrillation (AF) is associated with higher mortality. Biomarkers may improve the understanding of key pathophysiologic processes in AF that lead to death. Using a new multiplex analytic technique, we explored the association between 268 biomarkers and cardiovascular (CV) death in anticoagulated patients with AF. Methods and results A case–cohort design with 1.8- to 1.9-year follow-up. The identification cohort included 517 cases and 4057 randomly selected patients from ARISTOTLE. The validation cohort included 277 cases and 1042 randomly selected controls from RE-LY. Plasma collected at randomization was analysed with conventional immunoassays and the OLINK proximity extension assay panels: CVDII, CVDIII, and Inflammation. Association between biomarkers and CV death was evaluated using Random Survival Forest, Boruta, and adjusted Cox-regression analyses. The biomarkers most strongly and consistently associated with CV death were as follows (hazard ratio for inter-quartile comparison [95% CI]): N-terminal pro-B-type natriuretic peptide [NT-proBNP; 1.63 (1.37–1.93)], cardiac troponin T [cTnT-hs; 1.60 (1.35–1.88)], interleukin-6 [IL-6; 1.29 (1.13–1.47)], growth differentiation factor-15 [GDF-15; 1.30 (1.10–1.53)], fibroblast growth factor 23 [FGF-23; 1.21 (1.10–1.33)], urokinase receptor [uPAR; 1.38 (1.16–1.64)], trefoil factor 3 [TFF3; 1.27 (1.10–1.46)], tumour necrosis factor receptor 1 [TNFR1; 1.21 (1.01–1.45)], TNF-related apoptosis-inducing ligand receptor 2 [TRAILR2; 1.18 (1.04–1.34)], and cathepsin L1 [CTSL1; 1.22 (1.07–1.39)]. Conclusion In this comprehensive screening of 268 biomarkers in anticoagulated patients with AF, the underlying mechanisms most strongly associated with CV death were cardiorenal dysfunction (NT-proBNP, cTnT-hs, CTSL1, TFF3), oxidative stress (GDF-15), inflammation (IL-6, GDF-15), calcium balance, vascular and renal dysfunction (FGF-23), fibrinolysis (suPAR), and apoptosis (TNFR1, TRAILR2). These findings provide novel insights into pathophysiologic aspects associated with CV death in AF. ClinicalTrials.gov identifier NCT00412984 and NCT00262600." @default.
• W3191008658 created "2021-08-16" @default.
• W3191008658 creator A5014449865 @default.
• W3191008658 creator A5016303786 @default.
• W3191008658 creator A5018419311 @default.
• W3191008658 creator A5029533765 @default.
• W3191008658 creator A5032798881 @default.
• W3191008658 creator A5056206844 @default.
• W3191008658 creator A5063591215 @default.
• W3191008658 creator A5067237537 @default.
• W3191008658 creator A5067347864 @default.
• W3191008658 creator A5078318313 @default.
• W3191008658 creator A5079046512 @default.
• W3191008658 creator A5081852908 @default.
• W3191008658 creator A5084746877 @default.
• W3191008658 date "2021-08-06" @default.
• W3191008658 modified "2023-10-16" @default.
• W3191008658 title "Using multimarker screening to identify biomarkers associated with cardiovascular death in patients with atrial fibrillation" @default.
• W3191008658 cites W1569358024 @default.
• W3191008658 cites W1739267533 @default.
• W3191008658 cites W189243586 @default.
• W3191008658 cites W1952338989 @default.
• W3191008658 cites W1972837977 @default.
• W3191008658 cites W1975483501 @default.
• W3191008658 cites W1977260572 @default.
• W3191008658 cites W1977645780 @default.
• W3191008658 cites W1979639369 @default.
• W3191008658 cites W1980658595 @default.
• W3191008658 cites W1981372060 @default.
• W3191008658 cites W1984849421 @default.
• W3191008658 cites W1997048679 @default.
• W3191008658 cites W1999468381 @default.
• W3191008658 cites W2001795898 @default.
• W3191008658 cites W2007937185 @default.
• W3191008658 cites W2010084870 @default.
• W3191008658 cites W2012048878 @default.
• W3191008658 cites W2035104435 @default.
• W3191008658 cites W2040385059 @default.
• W3191008658 cites W2043262554 @default.
• W3191008658 cites W2043476842 @default.
• W3191008658 cites W2062608061 @default.
• W3191008658 cites W2065942755 @default.
• W3191008658 cites W2094551185 @default.
• W3191008658 cites W2114238925 @default.
• W3191008658 cites W2115098571 @default.
• W3191008658 cites W2130073289 @default.
• W3191008658 cites W2136489990 @default.
• W3191008658 cites W2139957955 @default.
• W3191008658 cites W2143727405 @default.
• W3191008658 cites W2145179900 @default.
• W3191008658 cites W2153073383 @default.
• W3191008658 cites W2162508946 @default.
• W3191008658 cites W2195506720 @default.
• W3191008658 cites W2259162027 @default.
• W3191008658 cites W2469578646 @default.
• W3191008658 cites W2513430955 @default.
• W3191008658 cites W2545266774 @default.
• W3191008658 cites W2547084618 @default.
• W3191008658 cites W2613648288 @default.
• W3191008658 cites W2742106012 @default.
• W3191008658 cites W2748400555 @default.
• W3191008658 cites W2761202362 @default.
• W3191008658 cites W2800604728 @default.
• W3191008658 cites W2805556127 @default.
• W3191008658 cites W2910737182 @default.
• W3191008658 cites W2946004128 @default.
• W3191008658 cites W2972784087 @default.
• W3191008658 cites W3033990395 @default.
• W3191008658 cites W3093137506 @default.
• W3191008658 cites W3099478002 @default.
• W3191008658 cites W3102027041 @default.
• W3191008658 doi "https://doi.org/10.1093/cvr/cvab262" @default.
• W3191008658 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34358298" @default.
• W3191008658 hasPublicationYear "2021" @default.
• W3191008658 type Work @default.
• W3191008658 sameAs 3191008658 @default.
• W3191008658 citedByCount "13" @default.
• W3191008658 countsByYear W31910086582022 @default.
• W3191008658 countsByYear W31910086582023 @default.
• W3191008658 crossrefType "journal-article" @default.
• W3191008658 hasAuthorship W3191008658A5014449865 @default.
• W3191008658 hasAuthorship W3191008658A5016303786 @default.
• W3191008658 hasAuthorship W3191008658A5018419311 @default.
• W3191008658 hasAuthorship W3191008658A5029533765 @default.
• W3191008658 hasAuthorship W3191008658A5032798881 @default.
• W3191008658 hasAuthorship W3191008658A5056206844 @default.
• W3191008658 hasAuthorship W3191008658A5063591215 @default.
• W3191008658 hasAuthorship W3191008658A5067237537 @default.
• W3191008658 hasAuthorship W3191008658A5067347864 @default.
• W3191008658 hasAuthorship W3191008658A5078318313 @default.
• W3191008658 hasAuthorship W3191008658A5079046512 @default.
• W3191008658 hasAuthorship W3191008658A5081852908 @default.
• W3191008658 hasAuthorship W3191008658A5084746877 @default.
• W3191008658 hasBestOaLocation W31910086581 @default.
• W3191008658 hasConcept C126322002 @default.
• W3191008658 hasConcept C134018914 @default.
• W3191008658 hasConcept C136935669 @default.
• W3191008658 hasConcept C143998085 @default.

• next